

share
Tuvirumab CAS NO 138660-97-6
Unit Price:
CAS No.:138660-97-6
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Tuvirumab CAS NO 138660-97-6 is a monoclonal antibody (mAb) therapeutic agent, representing a critical tool in targeted immunotherapy. Its primary value lies in its specific binding affinity, which enables precise intervention in disease pathways. This product is essential for research and development in the biopharmaceutical sector, particularly for organizations focused on oncology and immunology.
Application
- Biopharmaceutical Research & Development: A key reference standard for the development and validation of novel therapeutic antibodies and biosimilars.
- Preclinical & Clinical Studies: Used in in vitro and in vivo studies to investigate mechanisms of action, pharmacokinetics, and efficacy.
- Diagnostic Assay Development: Serves as a critical component in the creation of immunoassays, ELISA kits, and other diagnostic tools for biomarker detection.
- Cell Biology & Immunology Research: Employed to study specific cell surface receptors, signal transduction pathways, and immune cell functions.
- Quality Control & Validation: Acts as a positive control or comparator in the quality assurance testing of related biopharmaceutical products.
Basic Information
| Product Name | Tuvirumab |
| CAS No. | 138660-97-6 |
| Molecular Formula | Contact for details |
| Molecular Weight | Approx. 150 kDa (Monoclonal IgG) |
| Synonyms | Anti-CD147 monoclonal antibody; Tuvirumab (INN); CD147 mAb; Basigin monoclonal antibody; EMMPRIN antibody; 5A12; TUV; Monoclonal antibody to CD147 |
| EINECS | Not listed / Contact for details |
Quality Control
Our biopharmaceutical products are manufactured and tested under stringent quality systems. Each batch of Tuvirumab is subjected to a comprehensive panel of analytical tests to ensure identity, purity, potency, and safety, adhering to relevant ICH guidelines. A detailed Certificate of Analysis (COA), including data on purity (by SEC-HPLC and CE-SDS), endotoxin levels, sterility, and binding activity, is provided with every shipment.
Storage
Preserve in a tightly closed container, protected from light. For long-term stability, store at -20°C or below. Avoid repeated freeze-thaw cycles. Upon receipt, aliquot as needed and store under recommended conditions. The product is hygroscopic (moisture-sensitive).
Specification
| Item | Specification |
|---|---|
| Appearance | Clear to slightly opalescent, colorless to pale yellow solution |
| Identification (SEC-HPLC / CE-SDS) | Conforms to reference standard |
| Purity (Monomer by SEC-HPLC) | ≥ 95.0% |
| Protein Concentration (A280) | 1.0 ± 0.2 mg/mL (or as specified) |
| Potency (Binding ELISA / SPR) | ≥ 90% relative activity |
| Endotoxin | < 1.0 EU/mg |
| Sterility (Membrane Filtration) | Sterile |
| Buffer | PBS, pH 7.2 - 7.6 |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Pembrolizumab CAS NO 1374853-91-4


Biciromab CAS NO 138783-13-8


Muromonab-Cd3 CAS NO 140608-64-6


Anti-Stromelysin-2 CAS NO 140610-48-6


Gendevit CAS NO 141910-80-7


Edrecolomab CAS NO 156586-89-9


Felvizumab CAS NO 167747-20-8


Faralimomab CAS NO 167816-91-3


Rovelizumab [Usan:Inn] CAS NO 197099-66-4


Teprotumumab CAS NO 1036734-93-6


Monalizumab CAS NO 1228763-95-8


Anifrolumab CAS NO 1326232-46-5


Anti-Br140-Like Protein Antibody Produced In Rabbit CAS NO 1597439-92-3


Eptinezumab CAS NO 1644539-04-7


Rhumab Cd 168 CAS NO 211323-03-4


Ociperlimab CAS NO 2342597-93-5


Tadocizumab CAS NO 339086-80-5


Galiximab CAS NO 357613-77-5


Tocilizumab CAS NO 375823-41-9


Pritumumab CAS NO 499212-74-7
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






